PD
VERA icon

Point72 (DIFC)’s Vera Therapeutics VERA Stock Holding History

Point72 (DIFC)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$109K Buy
+3,735
New +$86.4K 0.01% 562
2024
Q4 		– Sell
-43,789
Closed -$1.94M – 1933
2024
Q3 		$1.94M Buy
43,789
+3,376
+8% +$128K 0.07% 345
2024
Q2 		$1.46M Buy
40,413
+38,425
+1,933% +$1.52M 0.05% 410
2024
Q1 		$85.7K Buy
+1,988
New +$70.8K ﹤0.01% 1111

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 (DIFC)'s VERA Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Vera Therapeutics (VERA) in Q3 2025: 3,735 shares worth $109K. The stake represents 0.01% of the portfolio and ranks #562 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in VERA as recently as Q3 2024.

Point72 (DIFC) first reported a position in VERA in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.94M in Q3 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Point72 (DIFC) held 3,735 shares of Vera Therapeutics worth $109K as of Q3 2025.
  • Vera Therapeutics was a new Point72 (DIFC) position in Q3 2025.
  • Vera Therapeutics made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #562 holding.
  • Point72 (DIFC) first reported a position in Vera Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Point72 (DIFC)'s Vera Therapeutics position peaked at $1.94M in Q3 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.